Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Versus Systems Inc. Common Stock (VS)

https://www.versussystems.com

Versus Systems Inc is a Canada based company. The company is engaged in the technology sector and is developing a business-to-business software platform that allows video game publishers and developers to offer prize-based matches of their games to their players. The product offerings of the company include Dashboard/Platform In-Game Experience and Versus Gear App.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

3,583,600

Shares Outstanding

2,480,000

Weighted SO

2,506,250

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

MSGM --.--%

FOXO --.--%

FRGT --.--%

QNRX --.--%

KPRX --.--%

Beta

1.9510

Last Div

0.0000

Range

1.23-20.8

Chg

-0.0200

Avg Vol

1219609

Mkt Cap

3583600

Exch

NASDAQ

Country

CA

Phone

604 639 4457

DCF Diff

1.7379

DCF

-0.3049

Div Yield

0.0000

P/S

32.3997

EV Multiple

-0.5440

P/FV

1.9934

Div Yield %

0.0000

P/E

-0.3767

PEG

-0.0708

Payout

0.0000

Current Ratio

196.1015

Quick Ratio

196.1015

Cash Ratio

97.0866

DSO

33.8250

DIO

0.0000

Op Cycle

33.8250

DPO

0.0000

CCC

33.8250

Gross Margin

-10.2043

Op Margin

-58.2208

Pretax Margin

-91.0258

Net Margin

-86.0063

Eff Tax Rate

0.0521

ROA

-5.1963

ROE

-1.0260

ROCE

-3.5356

NI/EBT

0.9449

EBT/EBIT

1.5635

EBIT/Rev

-58.2208

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-387.5755

CF/Debt

0.0000

Equity Multi

1.0183

Rec Turnover

10.7908

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

125.9749

Asset Turnover

0.0604

OCF/Share

-1.9917

FCF/Share

-1.9956

Cash/Share

0.3615

OCF/Sales

-45.1269

FCF/OCF

1.0019

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-519.5270

Div&CapEx Cov

-519.5270

P/BV

1.9934

P/B

1.9934

P/S

32.3997

P/E

-0.3767

P/FCF

-0.7166

P/OCF

-0.7180

P/CF

-0.7180

PEG

-0.0708

P/S

32.3997

EV Multiple

-0.5440

P/FV

1.9934

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jul 24, 01:19 Sands Q2 Revenue Up 15 Percent GlobeNewswire Inc. Jul 23, 01:22 Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants GlobeNewswire Inc. Jul 20, 23:47 VSTS IMPORTANT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Vestis Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – VSTS GlobeNewswire Inc. Jul 17, 05:00 Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance GlobeNewswire Inc. Jul 16, 23:39 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, Reckitt, and Tempus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 15, 05:30 Topflight Pharma Development Veteran Joins Synendos GlobeNewswire Inc. Jul 14, 06:00 Tryg-aktier handles eksklusive udbytte GlobeNewswire Inc. Jul 14, 06:00 Tryg shares are traded ex-dividend GlobeNewswire Inc. Jul 12, 19:12 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, Reckitt, and Tempus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 08, 23:20 ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VSTS GlobeNewswire Inc. Jul 08, 05:15 Novartis receives approval for first malaria medicine for newborn babies and young infants GlobeNewswire Inc. Jul 06, 14:00 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines - VSTS GlobeNewswire Inc. Jul 05, 21:54 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VSTS GlobeNewswire Inc. Jul 01, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, and Tempus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 26, 06:00 Tryg A/S – Q2 2025 pre-silent newsletter GlobeNewswire Inc. Jun 24, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, and Tempus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 17, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, Tempus, and Rocket and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 14, 00:33 VSTS Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vestis Corporation GlobeNewswire Inc. Jun 12, 21:51 VSTS Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vestis Corporation GlobeNewswire Inc. Jun 12, 06:00 Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH

Revenue Product Segmentation